Total Payments
$9,143
2024 Payments
$733.92
Companies
23
Transactions
496
Medicare Patients
1,163
Medicare Billing
$136,426
Payment Breakdown by Category
Food & Beverage$8,819 (96.5%)
Education$301.27 (3.3%)
Other$22.60 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,819 | 485 | 96.5% |
| Education | $301.27 | 10 | 3.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $22.60 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $3,033 | 190 | $0 (2024) |
| ViiV Healthcare Company | $2,141 | 115 | $0 (2024) |
| Janssen Biotech, Inc. | $1,108 | 55 | $0 (2023) |
| Merck Sharp & Dohme LLC | $773.92 | 48 | $0 (2024) |
| ABBVIE INC. | $556.80 | 27 | $0 (2024) |
| Janssen Products, LP | $345.37 | 4 | $0 (2018) |
| Insmed, Inc. | $186.03 | 8 | $0 (2021) |
| Theratechnologies Inc. | $181.92 | 8 | $0 (2022) |
| La Jolla Pharmaceutical Company | $146.68 | 6 | $0 (2024) |
| Paratek Pharmaceuticals, Inc. | $140.26 | 7 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $733.92 | 38 | Gilead Sciences, Inc. ($360.90) |
| 2023 | $940.35 | 51 | ViiV Healthcare Company ($336.65) |
| 2022 | $1,155 | 63 | Gilead Sciences, Inc. ($559.49) |
| 2021 | $1,373 | 82 | Gilead Sciences, Inc. ($491.57) |
| 2020 | $777.22 | 55 | Gilead Sciences, Inc. ($305.60) |
| 2019 | $1,380 | 69 | Gilead Sciences, Inc. ($453.78) |
| 2018 | $1,285 | 64 | Janssen Biotech, Inc. ($440.83) |
| 2017 | $1,499 | 74 | Gilead Sciences Inc ($361.85) |
All Payment Transactions
496 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: HIV | ||||||
| 12/18/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.78 | General |
| 12/11/2024 | La Jolla Pharmaceutical Company | XACDURO (Drug) | Food and Beverage | In-kind items and services | $28.16 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/20/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/13/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.23 | General |
| 11/06/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: HIV | ||||||
| 11/06/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: HIV | ||||||
| 10/23/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $26.56 | General |
| Category: HIV | ||||||
| 10/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.51 | General |
| 10/09/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $11.73 | General |
| 10/03/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.11 | General |
| 09/26/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.01 | General |
| 09/19/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.59 | General |
| 08/21/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.14 | General |
| 08/14/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/30/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: HIV | ||||||
| 07/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.79 | General |
| 07/10/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/04/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO, DALVANCE | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/26/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.80 | General |
| 05/31/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $25.03 | General |
| Category: VIROLOGY | ||||||
| 05/22/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.13 | General |
| 04/24/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.72 | General |
| 04/19/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.56 | General |
| 04/10/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO, DIFICID | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: INFECTIOUS DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 406 | 688 | $168,937 | $53,572 |
| 2022 | 4 | 288 | 418 | $104,696 | $32,067 |
| 2021 | 4 | 283 | 410 | $95,744 | $29,946 |
| 2020 | 3 | 186 | 284 | $66,498 | $20,842 |
Total Patients
1,163
Total Services
1,800
Medicare Billing
$136,426
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 220 | 476 | $94,724 | $31,782 | 33.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 138 | 151 | $57,531 | $16,503 | 28.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 30 | 42 | $12,768 | $3,828 | 30.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 19 | $3,914 | $1,459 | 37.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 179 | 301 | $59,899 | $18,444 | 30.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 75 | 75 | $28,575 | $8,716 | 30.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 21 | 21 | $9,838 | $2,873 | 29.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 13 | 21 | $6,384 | $2,034 | 31.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 193 | 310 | $61,690 | $19,413 | 31.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 64 | 64 | $24,384 | $7,314 | 30.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 14 | 23 | $6,992 | $2,271 | 32.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 12 | 13 | $2,678 | $947.32 | 35.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 131 | 219 | $43,581 | $14,310 | 32.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 41 | 41 | $15,621 | $4,777 | 30.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 14 | 24 | $7,296 | $1,755 | 24.1% |
About Dr. Rebecca Shaffer, MD
Dr. Rebecca Shaffer, MD is a Infectious Disease healthcare provider based in Silver Spring, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104932805.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rebecca Shaffer, MD has received a total of $9,143 in payments from pharmaceutical and medical device companies, with $733.92 received in 2024. These payments were reported across 496 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($8,819).
As a Medicare-enrolled provider, Shaffer has provided services to 1,163 Medicare beneficiaries, totaling 1,800 services with total Medicare billing of $136,426. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Silver Spring, MD
- Active Since 08/23/2006
- Last Updated 12/17/2013
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1104932805
Products in Payments
- DOVATO (Drug) $694.20
- TRIUMEQ (Drug) $553.27
- PREZCOBIX (Drug) $460.73
- CABENUVA (Biological) $404.42
- Symtuza (Drug) $367.81
- RUKOBIA (Drug) $240.56
- MAVYRET (Drug) $238.60
- DIFICID (Drug) $206.37
- AVYCAZ (Drug) $188.93
- Arikayce (Drug) $186.03
- ZERBAXA (Drug) $174.78
- SYMTUZA (Drug) $174.68
- ISENTRESS (Drug) $173.08
- PREZISTA (Drug) $164.23
- PIFELTRO (Drug) $147.78
- NUZYRA (Drug) $140.26
- JULUCA (Drug) $140.09
- TROGARZO (Drug) $131.33
- Truvada (Drug) $118.82
- XERAVA (Drug) $118.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Silver Spring
Dr. Phuong Trinh
Infectious Disease — Payments: $220,875
Infectious Disease $220,875
Michael Koren, M.d, M.D
Infectious Disease — Payments: $106,100
Infectious Disease $106,100
Dr. Lynette Posorske, Md, MD
Infectious Disease — Payments: $79,479
Infectious Disease $79,479
Barbara Matthews, Md, Mph, MD, MPH
Infectious Disease — Payments: $36,685
Infectious Disease $36,685
Vasilios Pyrgos, Md, MD
Infectious Disease — Payments: $7,622
Infectious Disease $7,622
Dr. John Mcneil, M.d, M.D
Infectious Disease — Payments: $1,655
Infectious Disease $1,655